Cancer cells with a mutated SETD2 gene were killed by a drug called AZD1775 that inhibits a protein called WEE1 in a recent study. It is well known that mutations drive cancer cell growth and resistance to treatment. However, these mutations can also become a weak point for a tumor. The research team found that that was the case for cancer cells with mutations in a key cancer gene called SETD2.
Around the web
New treatment targets cancers with particular genetic signature
Ready to get ripped?
Introducing the BEST SELLING diet and training program to get you beach-ready for summer.
Author Clint Nielsen
Clint is a dad and husband trying to stay in shape. He's also a highly opinionated fitness enthusiast and author of Reveal The Steel. Follow him on: Instagram, Twitter, Facebook and Google+